HROW241115P27000
- 0.00
- 0.000.00%
Harrow Newsroom
Harrow Announces Participation in Upcoming Investor Conferences
Harrow Inc. Reports Strong Q3 2024 Growth
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript Summary
Harrow Down Nearly 13%, on Pace for Largest Percent Decrease Since November 2023 -- Data Talk
Express News | Harrow Shares Down 18% After Q3 Revenue Misses Estimate
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Wall Street Set to Open Flat Thursday; Initial Jobless Claims Lower Than Forecast
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Top Premarket Decliners
Harrow Health: Strong Growth Prospects Amid Market Overreaction
10-Q: Quarterly report
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
U.S. stocks fluctuate丨Harrow plummets nearly 24% in pre-market trading, with Q3 revenue increasing but below expectations.
November 14th, Harrow plunged nearly 24% to $39.46 before the market opened. The company's core diluted net loss in the third quarter was $0.05 per share, lower than the $0.09 per share in the same period last year, analysts expect normalized earnings per share to be $0.07; quarterly revenue was $49.3 million, higher than the $34.3 million in the same period last year, analysts expect it to be $52.8 million. (Gelonghui)
Stocks to Watch: Cisco Systems, Beazer Homes, Harrow
Harrow Shares Fall 25% After 3Q Results Miss Estimates
Harrow Q3 Core Loss Narrows, Revenue Increases
Harrow Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results.